n-Propanol extract of boiled and fermented koro benguk (Mucuna pruriens seed) shows a neuroprotective effect in paraquat dichloride-induced Parkinson's disease rat model
- PMID: 30410229
- PMCID: PMC6200579
- DOI: 10.14202/vetworld.2018.1250-1254
n-Propanol extract of boiled and fermented koro benguk (Mucuna pruriens seed) shows a neuroprotective effect in paraquat dichloride-induced Parkinson's disease rat model
Abstract
Aim: n-Propanol extracts from fresh, boiled, and fermented seeds were studied to evaluate their neuroprotective effects in a Parkinson's disease (PD) rat model, based on the total number of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc).
Materials and methods: Rats were induced with paraquat dichloride at a dosage of 7 mg/kg BW intraperitoneally twice a week and at the same time supplemented with extract at a dosage of 70 mg/kg BW orally every day for 3 weeks. On the 24th day, all rats were perfused and fixed with 4% paraformaldehyde. The left part of the SNpc was processed for immunohistochemical staining with tyrosine hydroxylase (TH)-antibody. The total number of DA neurons in SNpc was evaluated with a stereological method.
Results: TH-immunoreactive cells found in the SNpc were identified as DA neurons. The average total number of DA neurons in the SNpc increased significantly in the PD rat model that was given an n-propanol extract of boiled and fermented seeds compared with a control PD rat model. Surprisingly, there was no significant difference in the average total number of DA neurons in SNpc between the PD rat model that was given n-propanol extract of fresh seeds and the control PD rat model.
Conclusion: n-Propanol extract of boiled and fermented seeds could produce a higher neuroprotective effect against DA neuron than fresh seeds in a PD rat model.
Keywords: Mucuna pruriens; Parkinson’s disease; animal model; neuroprotective; paraquat dichloride.
Figures

Similar articles
-
Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.PLoS One. 2016 Oct 27;11(10):e0164094. doi: 10.1371/journal.pone.0164094. eCollection 2016. PLoS One. 2016. PMID: 27788145 Free PMC article.
-
Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquat-induced Parkinsonian mouse model.Neurochem Int. 2013 Jun;62(8):1039-47. doi: 10.1016/j.neuint.2013.03.015. Epub 2013 Apr 3. Neurochem Int. 2013. PMID: 23562769
-
Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson's Disease through NF-κB/pAKT Signaling Pathways.Front Aging Neurosci. 2017 Dec 19;9:421. doi: 10.3389/fnagi.2017.00421. eCollection 2017. Front Aging Neurosci. 2017. PMID: 29311905 Free PMC article.
-
Optimization of Parkinson's disease therapy with plant extracts and nutrition's evolving roles.IBRO Neurosci Rep. 2024 May 24;17:1-12. doi: 10.1016/j.ibneur.2024.05.011. eCollection 2024 Dec. IBRO Neurosci Rep. 2024. PMID: 38872839 Free PMC article. Review.
-
Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models.Parkinsons Dis. 2019 Oct 30;2019:1349509. doi: 10.1155/2019/1349509. eCollection 2019. Parkinsons Dis. 2019. PMID: 31781363 Free PMC article. Review.
Cited by
-
Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor-kappa β and cathepsin B.Drug Deliv Transl Res. 2024 Feb;14(2):400-417. doi: 10.1007/s13346-023-01407-7. Epub 2023 Aug 19. Drug Deliv Transl Res. 2024. PMID: 37598133 Free PMC article.
-
Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective.3 Biotech. 2020 Dec;10(12):522. doi: 10.1007/s13205-020-02532-7. Epub 2020 Nov 10. 3 Biotech. 2020. PMID: 33194526 Free PMC article. Review.
-
Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.Neurochem Res. 2022 Jul;47(7):1816-1829. doi: 10.1007/s11064-022-03591-3. Epub 2022 Apr 5. Neurochem Res. 2022. PMID: 35380400 Review.
References
-
- WHO. The World Health Report 1998-Life in the 21st Century: A Vision for All. Geneva: World Health Organization; 1998.
-
- WHO. Neurological Disorders: Public Health Challenges. Geneva: World Health Organization; 2006.
-
- Mackenzie I.R.A. Neuropathology of atypical parkinsonian disorders. In: Litvan I, editor. Atypical Parkinsonian Disorders. Current Clinical Neurology. Philadelphia, PA: Humana Press; 2005.
-
- Uversky V.N. Neurotoxicant-induced animal models of Parkinson's disease: Understanding the role of rotenone, maneb, and paraquat in neurodegeneration. Cell Tissue Res. 2004;318:225–241. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous